Free Guide to Understanding Diabetes Clinical Trials

What Clinical Trials Are and How They Work

A clinical trial is a research study that tests whether a new medical treatment, medication, or device works in people. Before any diabetes treatment reaches patients through regular doctors' offices, it must go through years of testing. Clinical trials are a major part of that testing process.

Clinical trials follow a specific structure called phases. Phase 1 trials involve a small group of people—often 20 to 100—and focus mainly on safety. Researchers want to know if a new drug causes harmful side effects and what dose might work. Phase 2 trials expand to several hundred people and start looking at whether the treatment actually works for the condition being studied. Phase 3 trials involve hundreds or even thousands of people and compare the new treatment to existing treatments or a placebo (a pill or injection with no active medicine). If a treatment passes Phase 3, it may be approved by the U.S. Food and Drug Administration (FDA) for use by the general public. Phase 4 trials continue after a treatment is approved and available, monitoring long-term effects in larger populations.

For diabetes specifically, clinical trials test new insulin types, new medications that help the body use insulin better, devices that monitor blood sugar, and approaches that might prevent or reverse diabetes. Some trials focus on Type 1 diabetes, some on Type 2 diabetes, and some on both.

Participation in a clinical trial is always voluntary. People who join are called participants or subjects. They receive free medical care and monitoring related to the trial, though they may or may not receive the new treatment being tested—some participants receive a placebo instead as part of the research design.

Practical Takeaway: Understanding that clinical trials are structured, multi-phase research studies helps you recognize why they matter for developing new diabetes treatments and why researchers need people to participate in them.

Why Clinical Trials Matter for Diabetes Treatment

Diabetes affects over 37 million people in the United States, according to the Centers for Disease Control and Prevention. About 1.5 million new cases are diagnosed each year. Despite the availability of many treatments, many people still struggle to control their blood sugar levels, experience side effects from medications, or face complications from the disease. This is why researchers continue to develop new approaches.

Clinical trials are the only ethical way to test whether new treatments work better, are safer, or have fewer side effects than existing options. Without clinical trials, doctors would have no scientific evidence that a new medicine actually helps patients. The FDA requires clinical trial data before approving any new diabetes medication or device for widespread use.

Innovation in diabetes care has come directly from clinical trials. Long-acting insulin formulations, continuous glucose monitors, insulin pumps, and newer oral medications that reduce heart disease risk in Type 2 diabetes all started in clinical trials. These advances have improved quality of life and health outcomes for millions of people. Current trials are testing even newer approaches, including artificial pancreas systems that automatically adjust insulin delivery, medications that might reverse Type 2 diabetes, and potential preventive treatments for people at high risk of developing the disease.

Clinical trials also help identify which treatments work best for different groups of people. Diabetes affects people differently based on age, genetics, body weight, and other factors. A treatment that works well for one person might not work as well for another. Large, diverse clinical trials help researchers understand these differences and develop more targeted approaches.

Practical Takeaway: Clinical trials drive real progress in diabetes treatment, and the information they generate benefits everyone with diabetes, not just trial participants.

Types of Diabetes Clinical Trials Currently Underway

Diabetes research is active across multiple areas, and understanding the different types of trials can help you learn what research is happening and what each trial aims to accomplish.

Medication Trials: These test new drugs or new combinations of existing drugs. For Type 2 diabetes, many current trials focus on medications that work through different mechanisms—some help the pancreas release more insulin, some help the body use insulin more effectively, some reduce glucose production by the liver, and some help the kidneys remove excess glucose through urine. For Type 1 diabetes, trials test new forms of insulin, medications that might help preserve remaining insulin production, and drugs that could prevent the immune system from attacking insulin-producing cells.

Device Trials: These test new tools for managing diabetes. Continuous glucose monitors that track blood sugar automatically throughout the day are an example. Closed-loop systems—sometimes called "artificial pancreas" systems—automatically adjust insulin delivery based on glucose readings. Trials are also testing new insulin pump features, smartphone apps that help with diabetes management, and non-invasive glucose monitoring devices.

Combination Trials: These test a new medication alongside a device or compare a new drug combination to standard treatment. For example, a trial might test whether a new medication works better when combined with a continuous glucose monitor or intensive diabetes education.

Prevention Trials: These enroll people who do not yet have diabetes but have risk factors (such as prediabetes, family history, or obesity) and test whether a medication or lifestyle intervention can prevent or delay the development of Type 2 diabetes.

Behavioral or Lifestyle Trials: These test new approaches to education, support, diet programs, or exercise interventions to see if they improve blood sugar control or other health outcomes.

Practical Takeaway: Different types of trials answer different research questions, ranging from testing new medications to improving how people manage diabetes day-to-day.

What to Expect During a Clinical Trial

If someone enrolls in a diabetes clinical trial, the experience typically includes several stages. Before the trial begins, there is a screening visit. During screening, a potential participant meets with the research team, has blood tests and other measurements taken, and learns about the trial's specific requirements. The research team explains what will happen, what risks might exist, and what benefits might result. This is when questions can be asked and concerns discussed. Not everyone who is screened will be enrolled—the trial has specific requirements, and screening helps determine whether someone's health status and ability to participate match what the trial needs.

Once enrolled, baseline visits establish starting measurements. Blood sugar levels, weight, blood pressure, and other health markers are recorded. These measurements provide a point of comparison to assess whether the treatment makes a difference.

During the trial itself, participants may visit the research site monthly, every few months, or on another schedule depending on the trial. Each visit typically includes blood tests, vital signs (blood pressure, weight), and assessments of how the treatment is working. Some trials require keeping a daily log of blood sugar readings or medication use. Participants may be asked to follow certain diet or exercise recommendations. They may receive phone calls or messages between visits to check on their well-being or collect information about side effects.

The trial duration varies widely. Some trials last a few months, while others continue for a year or longer. Participants who experience serious side effects or whose health changes significantly may be withdrawn from the trial early, which is a safety measure.

At the end of the trial, there is usually a final visit with more testing and discussion of results. Participants learn what was learned from the trial, though the full results may not be available immediately—data analysis can take months.

Practical Takeaway: Participating in a clinical trial involves multiple visits, tests, and monitoring, so understanding the time commitment and structure helps people decide whether participation fits their situation.

How to Find Diabetes Clinical Trials

Finding a clinical trial that matches someone's needs and location involves knowing where to look and what information to gather.

ClinicalTrials.gov: This is a free, government-maintained database of clinical trials happening across the United States and some international locations. The website (clinicaltrials.gov) allows searching by condition (such as "Type 2 Diabetes"), location (state or city), and trial status (recruiting, ongoing, closed to new participants). Each trial listing includes the study title, a brief description, contact information, location, and detailed eligibility information. This is the most comprehensive source for finding trials.

Hospital and University Research Centers: Major medical centers often have their own research departments. Calling the diabetes clinic or research office at a hospital or teaching university can provide information about trials recruiting in that area. Many research institutions also have websites listing active trials.

Diabetes Organizations: Organizations like the American Diabetes Association,